Intraoperative Vancomycin Pharmacokinetics in Cardiac Surgery With or Without Cardiopulmonary Bypass
The Annals of Pharmacotherapy. 2013;47(4):455-463. The other purpose of our study was to examine the relationship between our antimicrobial prophylaxis protocol and the intraoperative serum vancomycin ...
Vancomycin is an effective glycopeptide antibiotic for gram-positive infections and is widely used to treat patients with methicillin-resistant Staphylococcus aureus (MRSA), Staphylococcus epidermidis ...
Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion after reconstitution and dilution. Not for prophylaxis of endophthalmitis. Renal insufficiency. Monitor hearing, blood, renal ...
Patients who sustain thermal injury may require adjustments of antibiotic dosing because of pharmacokinetic alterations and pathological changes that occur in this patient subset. In general, studies ...
The epidemiology, clinical severity, and case-fatality ratio of Clostridium difficile infection (CDI) changed dramatically with the emergence of a toxin hyperproducing strain (BI/NAP1/027) in North ...
Scientists at St. Boniface Hospital Albrechtsen Research Centre and the University of Manitoba have developed a drug that combats 2 of the top 10 "priority pathogens" recently defined by the World ...
Intraoperative Vancomycin Pharmacokinetics in Cardiac Surgery With or Without Cardiopulmonary Bypass
Background: Vancomycin is administered as antimicrobial prophylaxis to patients undergoing cardiac surgery, an intervention that usually requires cardiopulmonary bypass (CPB). Previous studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback